Your session is about to expire
← Back to Search
Total-Skin Electron Beam Therapy + Brentuximab for Skin Cancer
Study Summary
This trial is testing a new form of radiation therapy to see if it can help control mycosis fungoides, a type of skin cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 2 trial • 10 Patients • NCT01807598Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.My kidney function is severely impaired.I do not have any serious illnesses that would affect my treatment.I am on a stable dose of steroids, and stopping them might cause harm.My blood has Sezary cells but less than 1000 cells/microlitre.My skin cancer tested positive for CD30.I am not using other cancer treatments for mycosis fungoides or Sezary syndrome.I am capable of only limited self-care, confined to a bed or chair more than 50% of waking hours.My skin cancer is confirmed as mycosis fungoides at stage I-IV.I stopped my cancer treatment at least a week ago.I have moderate to severe nerve pain or tingling.My liver function is moderately or severely impaired.I am HIV positive, on stable HIV treatment for 12 weeks, and my CD4 count is over 200.
- Group 1: Brentuximab vedotin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are under care in this clinical trial?
"That is accurate. The information available on clinicaltrials.gov points to this trial actively recruiting patients as of right now. This trial was first posted on October 13th, 2020 and was last updated yesterday. They are looking for 30 individuals total, across one site."
Has Brentuximab vedotin received government approval for use?
"Brentuximab vedotin has only been studied in Phase 2 trials, so there is not enough evidence to support its efficacy. However, there is data suggesting that it is safe, so it received a score of 2."
Is this research study actively recruiting participants?
"Yes. The clinical trial is still recruiting participants, as noted on clinicaltrials.gov. The site was last updated on 10/14/2022, and the trial is looking for 30 more participants from 1 site."
Share this study with friends
Copy Link
Messenger